Karuna Therapeutics KRTX
$ 329.83
0.0%
Annual report 2023
added 02-22-2024
Country |
USA |
IPO year |
2019 |
Industry |
Biotechnology |
Stock Exchange |
NASDAQ GLOBALSPB |
CEO |
Dr. Steven Paul |
Employees in the company |
19 |
Shares |
37 M |
Market Cap[1] |
$ 12.2 B |
EBITDA (LTM) |
$ -312 M |
P/E (LTM) |
-15.25 |
P/S (LTM) |
- |
EPS (LTM) |
-11.09 |
Other stocks of industry "Biotechnology"
References
- Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.